FHTX
Price
$4.62
Change
+$0.03 (+0.65%)
Updated
Nov 21, 04:59 PM (EDT)
Capitalization
261.27M
103 days until earnings call
Intraday BUY SELL Signals
NVAX
Price
$6.47
Change
+$0.25 (+4.02%)
Updated
Nov 21 closing price
Capitalization
1.05B
102 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FHTX vs NVAX

Header iconFHTX vs NVAX Comparison
Open Charts FHTX vs NVAXBanner chart's image
Foghorn Therapeutics
Price$4.62
Change+$0.03 (+0.65%)
Volume$5.26K
Capitalization261.27M
Novavax
Price$6.47
Change+$0.25 (+4.02%)
Volume$4.05M
Capitalization1.05B
FHTX vs NVAX Comparison Chart in %
FHTX
Daily Signal:
Gain/Loss:
NVAX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FHTX vs. NVAX commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Hold and NVAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (FHTX: $4.62 vs. NVAX: $6.47)
Brand notoriety: FHTX: Not notable vs. NVAX: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 93% vs. NVAX: 93%
Market capitalization -- FHTX: $261.27M vs. NVAX: $1.05B
FHTX [@Biotechnology] is valued at $261.27M. NVAX’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileNVAX’s FA Score has 1 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • NVAX’s FA Score: 1 green, 4 red.
According to our system of comparison, NVAX is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 6 TA indicator(s) are bullish while NVAX’s TA Score has 4 bullish TA indicator(s).

  • FHTX’s TA Score: 6 bullish, 4 bearish.
  • NVAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than NVAX.

Price Growth

FHTX (@Biotechnology) experienced а -1.49% price change this week, while NVAX (@Biotechnology) price change was -7.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

FHTX is expected to report earnings on Mar 05, 2026.

NVAX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVAX($1.05B) has a higher market cap than FHTX($261M). FHTX YTD gains are higher at: -2.119 vs. NVAX (-19.527). NVAX has higher annual earnings (EBITDA): 496M vs. FHTX (-88.7M). NVAX has more cash in the bank: 612M vs. FHTX (199M). FHTX has less debt than NVAX: FHTX (23.7M) vs NVAX (228M). NVAX has higher revenues than FHTX: NVAX (1.08B) vs FHTX (24.2M).
FHTXNVAXFHTX / NVAX
Capitalization261M1.05B25%
EBITDA-88.7M496M-18%
Gain YTD-2.119-19.52711%
P/E RatioN/A3.22-
Revenue24.2M1.08B2%
Total Cash199M612M33%
Total Debt23.7M228M10%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FHTXNVAX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 26 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
FHTX
Daily Signal:
Gain/Loss:
NVAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BWLYX26.650.43
+1.64%
American Beacon Man Lg Cp Value Y
IYBIX25.600.16
+0.63%
Macquarie Balanced Fund Class I
BMPIX98.70N/A
N/A
ProFunds Materials UltraSector Inv
NBPIX50.73N/A
N/A
Neuberger Berman Large Cap Value Instl
MXEBX16.83N/A
N/A
Empower Core Strategies US Eq Instl